Lyn Iemma, aged 75 years at the time of writing, would not describe her life as dramatic. Born and raised in Perth, WA, Australia, this thriving but relaxed city is the place she has always called ...

Collectively, the top eight blockbuster drugs of 2024 generated over $116 billion in sales last year. Looking closer at these ...

The final appraisal document for Dupixent (dupilumab ... aged over 12 with severe asthma characterised by type 2 inflammation and uncontrolled using standard drugs. They also need to be having ...

Dupixent has already picked up an additional approval as a treatment for severe asthma, and the French drugmaker is also eyeing testing it in phase 2 and 3 trials in chronic obstructive pulmonary ...

Many people with atopic dermatitis also have asthma or allergic rhinitis (nasal allergies ... This is how biologic treatments can help. Dupixent (dupilumab) was the first biologic treatment approved ...

The parents of Cole Schmidtknecht, 22, are suing Walgreens and OptumRx, a subsidiary of UnitedHealth Group, over the Wisconsin man's death in 2024.

United Health Group’s pharmacy benefit manager, Optum Rx, stopped covering Cole Schmidtknecht’s ‘life-changing’ inhaler, suit ...

Arizona Attorney General Kris Mayes on Thursday sued drug producer GlaxoSmithKline (GSK) for harm done to asthma patients by discontinuing a long-time product.

The SARS-CoV-2 pandemic interrupted much respiratory research. Respiratory clinical academics joined colleagues in providing clinical care, and global research efforts were directed to finding new ...

People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...

a Wellington Asthma Research Group, Wellington School of Medicine, P.O. Box 7343, Wellington, New Zealand, b Unit of Environmental Epidemiology, National Public Health Institute, P. O. Box 95, Kuopio, ...